Baader Bank Aktiengesellschaft lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 7.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 700 shares of the biotechnology company’s stock after purchasing an additional 46 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Axon Enterprise were worth $416,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in AXON. Public Sector Pension Investment Board increased its holdings in shares of Axon Enterprise by 79.5% in the second quarter. Public Sector Pension Investment Board now owns 2,604 shares of the biotechnology company’s stock valued at $766,000 after purchasing an additional 1,153 shares during the period. The Manufacturers Life Insurance Company lifted its position in Axon Enterprise by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 43,367 shares of the biotechnology company’s stock valued at $12,760,000 after purchasing an additional 535 shares during the period. Creative Planning boosted its holdings in Axon Enterprise by 9.6% in the second quarter. Creative Planning now owns 16,463 shares of the biotechnology company’s stock valued at $4,844,000 after purchasing an additional 1,441 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in Axon Enterprise by 30.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock worth $236,000 after purchasing an additional 188 shares during the period. Finally, EP Wealth Advisors LLC raised its stake in shares of Axon Enterprise by 18.3% during the 2nd quarter. EP Wealth Advisors LLC now owns 1,577 shares of the biotechnology company’s stock valued at $464,000 after buying an additional 244 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by corporate insiders.
Axon Enterprise Price Performance
Wall Street Analysts Forecast Growth
AXON has been the topic of several analyst reports. TD Cowen began coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. JMP Securities upped their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Finally, Robert W. Baird raised their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One equities research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $524.85.
View Our Latest Analysis on Axon Enterprise
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- Earnings Per Share Calculator: How to Calculate EPS
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The Role Economic Reports Play in a Successful Investment Strategy
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.